A rare occurrence of the association of parathyroid adenoma in a case of thyroid papillary carcinoma is described. The patient was incidentally found to have parathyroid adenoma which was preoperatively diagnosed to be a metastatic lymph node. Analysis of her serum obtained before operation showed an elevation of serum parathyroid hormone (PTH) concentration without hypercalcemia. Since the association of hyperparathyroidism is high in patients with thyroid diseases, examination of not only serum levels of calcium and PTH but also careful interpretation of computed tomography (CT) and/or nuclear magnetic imaging (MRI) is necessary in the diagnosis of co-existing asymptomatic hyperparathyroidism. (Internal Medicine 31: 459-462, 1992) Key words: serum PTH, normal serum calcium, computed tomography (CT), nuclear magnetic imaging (MRI)
Intr oduction
It has been reported that thyroid disease is common in patients with hyperparathyroidism, and vice versa (1) . Parathyroid adenoma is clinically recognized in patients presenting with either hypercalcemia or it may be a part of multiple endocrine neoplasia (MEN) type I and type Ha (2) . There have also been sporadic reports of the coexistence of hyperparathyroidism and nonmedullary thyroid carcinoma (3) (4) (5) (6) (7) (8) . Thus, the presence of hyper parathyroidism has to be kept in mind in patients with thyroid carcinoma. In such cases, hypercalcemia is a virtually inevitable laboratory finding and therefore, is an important laboratory finding in the diagnosis of hyperparathyroidism. Except for such conditions, it is very rare to find parathyroid adenoma. We have recently encountered a case of nonmedullary thyroid carcinoma (papillary carcinoma) associated with parathyroid adenoma which was initially diagnosed to be a metastatic lymph node of thyroid malignancy. She had neither radiologic abnormalities such as subperi osteal bone resorption nor symptoms associated with hyperparathyroidism. Since the elevated concentration of PTH normalized after operation, we speculate that the patient had asymptomatic hyperparathyroidism, namely parathyroid adenoma with the preclinical stage of hyperparathyroidism.
Materials and Methods
Serum concentrations of free T3 (FT3) and free T4 (FT4) were measured by analog method radioimmuno assay (RIA) kits (Amerlex FT3 and FT4, Amersham International, Tokyo, normal range of FT3 and FT4 are 2.3-5.7pg/ml and 0.80-2.10ng/dl, respectively. Serum TSH levels were measured by an immunoradiometric assay (IRMA) kit (Spac TSH, Daiichi Isotope Lab, Tokyo, with normal range of 0.1-5.0/^U/ml). Titers of anti-thyroglobulin (Tg) and anti-microsomal antibodies were measured by hemagglutination kits (Serodia-ATG, Serodia-AMC, Fujirebio Inc., Tokyo). Titers of serum anti-TSH receptor antibodies (TRAb) were measured using a commercially available radioreceptor assay kit (Baxter, Tokyo, normal range less than 10%). Serum calcitonin was measured by a double antibody RIA kit (Calcitonin kit Daiichi, Daiichi Isotope Lab, Tokyo, normal range, less that 100pg/ml) and an IRMA kit ELSA-hCT, CSI diagnostic, Osaka, normal range, less From the Third Department of Internal Medicine, Gifu University School of Medicine, Gifu, * the Department of Internal Medicine and ** Surgery, Hashima Municipal Hospital, Hashima Received for publication June 7, 1991 ; Accepted for publication September 12, 1991 Reprint requests should be addressed to Dr. Shigeki Sakata, the Third Department of Internal Medicine, Gifu University School of Medici Tsukasa-cho, Gifu 500, Japan were 10-90/ig/day, less than 12/ig/day, 100-700\j%l day, 2.6-9.2mg/day, and 1.5-6.6mg/day, respectively). Case Report
A 46-year-old woman consulted our hospital with the chief complaint of an enlarged thyroid gland. Her past history was unremarkable except for hypertension of three years which had been treated with anti-hypertensive drugs. There was no history of neck irradiation. She denied past history of urolithiasis, peptic ulcer and pancreatitis. Family history disclosed that her mother and father had brain tumor and gastric cancer, respectively. On physical examination, her height was 154cm, weight 58.5 kg, blood pressure 166/90mmHg and pulse 96/min and regular. She had a rubbery hard, smooth surfaced nodule (20 X 20 mm) on her right thyroid gland which was solid by CT and MRI imagings. Superficial lymph nodes were not palpable. Chest, heart and abdo men were unremarkable. Patellar and Achilles' jerks were normal. There was no edema in her legs. Routine laboratory tests including serum albumin (4.1 g/dl) were unremarkable. Serum calcium and phos phorus concentrations were normal, being 4.6mEq/l and 3.0mg/dl, respectively. Urinalysis was normal. On thyroid function test, she had normal serum free thyroid hormones (FT3; 3.4pg/ml, FT4; 0.94ng/dl, with high normal basal TSH level (4.7 /iU/ml). Anti-Tg and anti microsomal antibodies were negative. Serum concen tration of calcitonin measured by a double antibody RIA was high, being 240pg/ml. However, measurement of the same sample with IRMA was normal, being 7.1pg/ml. Discrepancy of serum calcitonin values ob tained by double antibody RIA and IRMA is difficult to interpret at present. 99mTechnetium scintigraphy revealed a cold area in the right lobe of the thyroid (Fig. 1A) and 201Thallium scintigraphy showed an accumulation of radioactivity in the same area (Fig. IB) . Computed tomography (CT) and nuclear magnetic imaging (MRI) of the thyroid gland disclosed a solid tumor in the right lobe and an enlarged lymph node in its lower pole (Figs. 2 and 3 ). Since aspiration biopsy and cytology (ABC) of the thyroid gland appeared suspicious of malignancy (class III) and the possible presence of metastatic lymph node was found based on CT and MRI findings, she underwent subtotal thyroidectomy in November 1988. During the operation several small tumors which were found in the lower pole of right thyroid lobe were removed. Histopathologic examination of removed specimen showed lymph nodes with metastatic lesion of thyroid papillary carcinoma. However, the histopathology of the biggest node revealed it to be a parathyroid adenoma. Since such a diagnosis was made, PTH concentration of serum which had been obtained before operation and kept frozen was measured retrospectively. It was shown that serum PTH was elevated (590 pg/ml). The level was normalized at two weeks and of 9 months after operation, being 320pg/ml, and 330pg/ml, respectively. Since two measurements of serum PTH concentration using the same serum obtaned prior to operation resulted in the same level, the diagnosis of hyperparathyroidism was confirmed. Immediate postoperative concentrations of serum albumin, calcium and phosphate were 4.1 g/dl, 4.4mEq/l and 3.0mg/dl, respectively, which were within the normal range. Serum calcium ion concen tration two weeks after operation was 2.48mEq/l which was also within the normal range (normal range, 2.24-2.58mEq/1). From these results it was concluded that the tumor in the lower pole of the right lobe of the thyroid gland as shown by CT and MRI was in fact a parathyroid adenoma. Since she had a past history of hypertension, the possibility of the presence of other endocrine abnormalities were examined postoperatively.
It was shown that serum concentrations of glucagon and gastrin were normal, being 64pg/ml and 120pg/ml, respectively. Urinary noradrenaline, adrenaline, dopa mine, VMA, and HVA were 76.7^g/day, 7.2/ig/day, 422/^g/day, 5.9mg/day, and 2.9mg/day, respectively, which were also within the normal range. Thus, the presence of other endocrine adenomas such as multiple endocrine neoplasia (MEN) type I and llamas ruled out. Discussion
The present patient underwent subtotal thyroidectomy for possible thyroid malignancy. During the operation several small tumors were found in the lower pole of the right lobe of the thyroid gland which were preopratively thought to be metastatic lymph nodes. Pathological examination however, disclosed that the biggest node removed was parathyroid adenoma. Thus, together with the elevated concentration of PTH, a diagnosis of thyroid papillary carcinoma associated with parathyroid adenoma was made. It has been reported that the apparent frequency of thyroid diseases in patients with hyperparathyroidism is high. The genetic association of hyperparathyroidism and medullary thyroid carcinoma has been well recog nized in the context of the multiple endocrine neoplasia, type II (2 There is a growing recognition that primary hyper parathyroidism is not a rare disease. One report stated that the annual incidence of hyperparathyroidism after introduction of routine measurement of serum calcium is 51.1±9.6 cases per 100,000 (0.051%) (10) . Other studies state that the prevalence among the adult popu lation in the United States is one case among 834-1,000
adults, for a prevalence of 0.12-0.10% (ll, 12) . How ever, it is extremely difficult to make a diagnosis of asymptomatic hyperparathyroidism without measure ment of the serum calcium concentration. In addition, it has been reported that hyperparathyroidism can be benign with only slight changes in bone density, function of other organs, or PTH or blood calcium levels (13) .
Since the association of hyperparathyroidism is high in patients with thyroid disease, it is very important not only to analyze the serum calcium levels but also to interpret carefully CT scan or MRI imagings in order to diagnose a slow progressive asymptomatic hyperpara thyroidism before operation of benign and/or malignant tumor is performed.
